Toledano Miranda Jayne
CIK 0001686530
Chief Executive OfficerDirector
Filings
15
Latest Dec 30, 2025
Issuers covered
3
Showing
15 of 15
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -4.0% | -14.3% | +48.2% | -25.1% |
| 90 days | 5 | 20% | +12.4% | -10.5% | +164.6% | -44.4% |
| 180 days | 4 | 25% | +23.8% | -36.1% | +216.9% | -49.5% |
| 365 days | 4 | 50% | +38.0% | +7.0% | +207.7% | -69.5% |
Issuers
Companies where Toledano Miranda Jayne has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ENTX | Entera Bio Ltd. | 8 | Dec 30, 2025 |
| DERM | Journey Medical Corp | 5 | Aug 7, 2025 |
| NXGL | Nexgel, Inc. | 2 | Aug 21, 2023 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|